The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...
(AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...